Adaptimmune Therapeutics plc (ADAP) dropped -5.82% or -0.27 to $4.37. It is close to 1.52 million shares traded, which is 520.36% compare to the average total volume 292174. The market cap of ADAP is $457.59 million. The year to date change is -22.06%. The 52 week price range is from $3.55 to $14.62. Price of ADAP have changed -0.64% during last week. It have changed -6.64% over last month, -4.72% over last 3 months, -28.94% over last 6 months and -65.14% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 4.35. It is -0.46% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for ADAP is 7.04. It is 61.10% above current price. The 52-week High is 14.62. It is 234.55% from the current price. The 52-week Low is 3.55. It is -18.76% from current price.
There are some statistics of ADAP. It is has market cap $457.59 million. The share outstanding is 104.71 million. The average volume is 292174. The percent of top 15 Institution holding is 74.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -42.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -34.24%.